ak 295 has been researched along with paclitaxel in 1 studies
Studies (ak 295) | Trials (ak 295) | Recent Studies (post-2010) (ak 295) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
13 | 0 | 0 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Culver, DG; Davis, AA; Glass, JD; Powers, JC; Wang, MS; Wang, Q | 1 |
1 other study(ies) available for ak 295 and paclitaxel
Article | Year |
---|---|
Calpain inhibition protects against Taxol-induced sensory neuropathy.
Topics: Animals; Antineoplastic Agents; Axons; Calpain; Caspases; Cell Death; Cell Line; Cells, Cultured; Dipeptides; Electrophysiology; Female; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Microtubules; Nerve Degeneration; Neurons, Afferent; Paclitaxel; Rats; Rats, Inbred Strains | 2004 |